 | |
|
| MUST is a multicenter, randomized controlled clinical trial, that will compare the fluocinolone acetonide implant to standard systemic therapy for the treatment of patients with non-infectious intermediate uveitis, posterior uveitis, or panuveitis. Study Website | |
|
| |